Related Articles
Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway10.3892/ijo.2024.5611
β‑catenin blockers enhance the effect of CDK4/6 inhibitors on stemness and proliferation suppression in endocrine‑resistant breast cancer cells
Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features
EZH2 inhibition sensitizes tamoxifen‑resistant breast cancer cells through cell cycle regulation
Differential microRNA expression profiles in tamoxifen-resistant human breast cancer cell lines induced by two methods